{"organizations": [], "uuid": "ce87e305084b937a8f53af886c03d3e7ff5661f9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/07/globe-newswire-cytori-to-webcast-first-quarter-financial-results-on-may-10.html", "country": "US", "domain_rank": 767, "title": "Cytori to Webcast First Quarter Financial Results on May 10", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.874, "site_type": "news", "published": "2018-05-08T00:15:00.000+03:00", "replies_count": 0, "uuid": "ce87e305084b937a8f53af886c03d3e7ff5661f9"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/07/globe-newswire-cytori-to-webcast-first-quarter-financial-results-on-may-10.html", "ord_in_thread": 0, "title": "Cytori to Webcast First Quarter Financial Results on May 10", "locations": [], "entities": {"persons": [{"name": "cytori", "sentiment": "none"}], "locations": [{"name": "san diego", "sentiment": "none"}], "organizations": [{"name": "cytori therapeutics, inc.", "sentiment": "neutral"}, {"name": "cytori therapeutics, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its first quarter financial results and business update on Thursday, May 10, 2018 at 5:30 PM Eastern Time.\nThe dial-in information is as follows:\nDial-In Number: +1.877.402.3914\nConference ID: 7194327\nPrior to the webcast at approximately 4:30 PM Eastern Time on May 10, Cytori will issue its first quarter earnings release which will review Cytori’s first quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.\nAbout Cytori Therapeutics, Inc.\nCytori is a therapeutics company developing regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for a variety of medical conditions. Cytori Nanomedicine™ is developing encapsulated therapies for regenerative medicine and oncologic indications using technology that allows Cytori to use the benefits of its encapsulation platform to develop novel therapeutic strategies and reformulate other drugs to optimize their clinical properties. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information, visit www.cytori.com .\nCytori Therapeutics, Inc.\nTiago Girao, 1.858.458.0900\nir@cytori.com\nSource:Cytori Therapeutics Inc", "external_links": ["https://www.globenewswire.com/Tracker?data=_SvVBSwO_yztZy0Bwc45548Zhgik46Apu4U1RRen-d4BMvr2Elygizc5tbGKfyfK1OQ46CwR2vyWU1JGLkFNFEaOeECC5KccUMGnCa638fOPx-rmO5iLHXc881jkQUaZdR-F2W3mvJ1zwwIktn-63A0ZH_217alIySEG35Alz0CiuTF-OiGxLyeAdMqk-re9Ola2z5GuCILqXI2L5Fv2Gw30PFeIUt5n_f685xRoRo5FMYAsCSe35PPRG-SoJnNAUc-svtqht5UDg3-NR8GIAAfyMdNYg5-XlnchVULOGkuutSirrHdGY6wGXd2yTIyfcu8ncRUbrk6nniAWHlXaIMuAgs_dlvDulCCkBEmiNj_fF7TN7MXcpmvlSIi7bpYZSjtIHxpuT7Wl084EVV7N6DP-maEX9mueoVkG8-nIMG3RtmryFVhttC6oeGrBddFoT0lVOpvEaCnjdLVD0dwMJ31fg7WwC4IzDUVyWDz", "https://www.globenewswire.com/Tracker?data=oN2P4vKnLyb8iKehyhan79B5uRvVdsovJwB3ezV47HSjGsSafgrsogbDYGI_bJPY9KBptRIoe-xk_K7-zg9uWA=="], "published": "2018-05-08T00:15:00.000+03:00", "crawled": "2018-05-08T00:22:29.000+03:00", "highlightTitle": ""}